CHEMBIOCHEM
FULL PAPERS
on the amino acid sequence of UniProt entry P51060. The gene
was under the control of a T7 promoter, and its codon usage had
been optimized for expression in E. coli. Competent cells of E. coli
strain BL21(DE3) were transformed with this plasmid and grown
overnight in medium (500 mL). Cell were harvested, washed in M9
medium, and used to inoculate 10 L of M9 medium. Cells were
grown up to an OD600 of ꢀ0.8. Expression of the TspPEPC gene
was induced by addition of IPTG (final concentration 0.2 mm) and
incubation at room temperature overnight. Harvested cells were
resuspended in buffer [Tris·HCl (pH 8, 50 mm), DTT (1 mm), ethyl-
enediaminetetraacetic acid (EDTA, 1 mm)] and disrupted by sonica-
tion. Particulate matter was removed from the lysate by ultracentri-
fugation (140000 g, 45 min). The supernatant was removed and
(NH4)2SO4 (40%, w/v) was added. The precipitate was collected by
centrifugation. The pellet was dissolved in buffer [Tris·HCl (pH 8,
50 mm), DTT (1 mm), EDTA (1 mm)], dialyzed against this buffer (2ꢁ
2 L) overnight, and centrifuged again to remove insoluble protein.
The supernatant was applied to a Q-Sepharose fast flow column
(GE Healthcare) equilibrated with buffer [Tris·HCl (pH 8, 50 mm),
DTT (1 mm), EDTA (1 mm)], and the protein was eluted with
a rising NaCl gradient in the same buffer (0–500 mm NaCl, three
column volumes). TspPEPC-containing fractions (as judged by an
SDS-PAGE gel) were pooled, concentrated to a final volume of
3 mL, applied to a Sephacryl S100 column (GE Healthcare) equili-
brated with buffer [Tris·HCl (pH 8, 50 mm), NaCl (150 mm)], and
eluted with the same buffer. TspPEPC-containing fractions were
pooled, concentrated, and frozen at À708C until use.
(Fisons), respectively. IR spectra were recorded with a Nicolet 6700
FTIR spectrometer. Melting points were determined with a “Dr. Tot-
toli apparatus” (Buchi Corporation) without correction.
2-(3-Nitrophenyl)[1-13C]acetonitrile (1): K13CN (0.42 g, 6.24 mmol) was
added to a solution of 1-(chloromethyl)-3-nitrobenzene (1.00 g,
5.85 mmol) and [18]crown-6 (0.15 g, 0.57 mmol) in acetonitrile
(10 cm3), and the bluish suspension was stirred for 24 h at 258C.
Methylene dichloride (25 cm3) was then added, and the now
brownish suspension was filtered. The filtrate was washed with
water (2ꢁ25 cm3), dried (MgSO4), and concentrated under reduced
pressure to afford a brownish oil, which was used in the following
step without further purification.
2-(3-Nitrophenyl)[1-13C]acetic acid (2, 13C-mNPAA, Scheme 1): A solu-
tion of crude 1 in half-concentrated HCl (20 cm3) was heated to
1008C for 18 h. After the system had cooled down, ethyl acetate
(20 cm3) was added, and the mixture was basified with aqueous
NaOH. The resulting combined aqueous extracts were acidified
with aqueous HCl and extracted with methylene dichloride. The
combined organic layers were dried over MgSO4 and concentrated
to afford product 2 (0.46 g, 45%) as a slightly brownish solid.
1H NMR (CDCl3, 250 MHz): d=8.15–8.18 (m, 2H), 7.62–7.65 (m, 1H),
7.49–7.56 (m, 1H), 3.79 ppm (d, J=8.0 Hz, 1H); 13C NMR (CDCl3,
250 MHz): d=176.29, 135.80, 135.15, 129.73, 124.67, 122.72, 116.65,
40.44 ppm (d, J=55.7 Hz).
2-(3-Nitrophenyl)acetonitrile (3): Potassium cyanide (3.8 g,
57.1 mmol) was added to a solution of 1-(chloromethyl)-3-nitro-
benzene (10.0 g, 58.5 mmol) and [18]crown-6 (1.5 g, 5.7 mmol) in
acetonitrile (100 cm3), and the greenish suspension was stirred for
18 h at 258C. Methylene dichloride (50 cm3) was then added, and
the now brownish suspension was filtered. The filtrate was washed
with water (2ꢁ50 cm3), dried (MgSO4), and concentrated under
reduced pressure to yield a brownish oil, which was fractionally
distilled in vacuo to afford product 3 (4.4 g, 48%) as a yellowish oil,
containing [18]crown-6 (6%). 1H NMR (CDCl3, 250 MHz): d=8.21–
8.23 (m, 2H), 7.71–7.74 (m, 1H), 7.57–7.64 (m, 1H), 3.89 ppm (s,
2H).
For use in the FTIR measurements, protein samples were buffer-ex-
changed and concentrated with Amicon centrifugation devices
and the buffer specific for the measurements, which also contained
the caged compound.
RuBisCO activity assays: RuBisCO activity was tested with a modi-
fied method based on that of Norton et al. in a Hitachi U-2000
spectrophotometer.[39] To avoid primary amines that might interfere
with carbamate formation, we used 4-(2-hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES, pKa 7.5) as a buffer instead of tris(hy-
droxymethyl)aminomethane (Tris).
2-(3-Nitrophenyl)[18O]acetic acid (4, 18O-mNPAA, Scheme 1): A solu-
tion of 3 (0.30 g) in H218O (1 cm3) in a screw-cap vial was exposed
to a stream of gaseous HCl for 2 h until the solution solidified. The
vial was sealed and heated for 24 h to 1008C. After the system had
cooled down, ethyl acetate was added, and the mixture was basi-
fied with aqueous NaOH. The resulting combined aqueous extracts
were acidified with aqueous HCl and extracted with methylene
dichloride. The combined organic layers were concentrated under
reduced pressure to afford 4 (0.4 g, 114%) as a slightly brownish
solid still containing some water. 1H NMR (CDCl3, 250 MHz): d=
8.16–8.18 (m, 2H), 7.62–7.65 (m, 1H), 7.49–7.56 (m, 1H), 3.79 ppm
(d, J=8.0 Hz, 1H); MS (ESÀ): m/z (%): 135.4 (100), 181.6 (6.8)
[MÀH]À 18O/16O, 183.7 (17.6), [MÀH]À 18O/18O.
TspPEPC activity assay: TspPEPC activity was tested in a modified
coupled assay with malate dehydrogenase[40] in the following mix-
ture: Tris acetate (pH 8.5, 0.1m), KHCO3 (10 mm), MgSO4 (10 mm),
potassium phosphoenolpyruvate (2 mm), acetyl-coenzyme A
(0.2 mm) as an allosteric activator, NADH (0.1 mm), malate dehydro-
genase (5 IU), TspPEPC (0.1–0.2 mgmLÀ1). The oxidation of NADH
to NAD was followed with a Hitachi U-2000 spectrophotometer. To
avoid primary amines that might interfere with carbamate forma-
tion, we used HEPES (pKa 7.5) as a buffer instead of Tris for the IR
measurements.
Syntheses
General: Unless otherwise noted, all reagents were obtained com-
mercially and used without further purification. Solvents for chro-
matography were technical grade and distilled prior to use. Sol-
vents for reactions were purchased as reagent grade and distilled
prior to use. Analytical TLC was performed on Macherey–Nagel
Polygram SIL G/UV254 precoated plastic sheets for TLC, and visuali-
zation was achieved by irradiation with UV light. Column chroma-
tography was performed with silica gel (Merck 60, particle size
0.040–0.063 mm). Solvent mixture ratios are understood as
(5-Nitro-1,3-phenylene)dimethanol (5): A solution of 5-nitroisophthal-
ic acid (4.3 g, 20.4 mmol) in tetrahydrofuran (25 cm3) was cooled to
08C, and borane-tetrahydrofuran (1n, 100 cm3, 100 mmol) was
added dropwise over 1 h. The mixture was allowed to warm up
slowly to 258C and stirred for 36 h. Methanol (20 cm3) was added
slowly, and the mixture was filtered and concentrated. The residue
was dissolved in ethyl acetate (30 cm3), washed with water (2ꢁ
15 cm3), dried (MgSO4), filtered, and concentrated to afford the
known compound 5 (3.6 g,98%) as a yellow solid, which was used
in the following step without further purification. 1H NMR (CDCl3,
250 MHz): d=8.15 (s, 2H), 7.72 (s, 1H), 4.82 ppm (s, 4H) was in line
with the literature.[41]
1
volume/volume. H NMR and 13C NMR spectra were recorded with
Bruker AM 250/AV 300 instruments in CDCl3/[D6]DMSO. ESI-MS/
MALDI-TOF mass spectra were obtained with a VG Platform II in-
strument with a Quadrupol Analyzer and a VG Tofspec instrument
ꢂ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ChemBioChem 2013, 14, 372 – 380 378